4 Mesothelioma Information

Industry Makes Request to Decrease Asbestos Regulations

2008-08-19T10:30:00.000-05:00

LegalView Offers Mesothelioma Blog Readers Details of Disconcerting Request to Decrease Asbestos Regulations from Industry

LegalView informed mesothelioma blog readers of an potentially troubling request by automotive, chemical and mining industries' paid researchers to "water down" asbestos regulations. The industry-hired scientists argued that asbestos is no longer as dangerous, even though several international health organizations have declared no safe level of the material.

Denver, CO - August 2, 2008 -- LegalView, the number one resource for everything and anything legal on the Internet, recently updated readers with the latest piece of mesothelioma information, relating to the request by paid researchers for the automotive, chemical and mining industries to decrease asbestos regulations. In a July 2008 summit in Washington D.C., the Environmental Protection Agency (EPA) met with the Office of Solid Waste and Emergency regarding the request. The industry researchers argued that asbestos fibers found in sand, taconite and other materials are less toxic than originally deemed in the 1980s when the regulations were created. However, the EPA along with the International Agency for Research on Cancer, the Occupational Safety and Health Administration (OSHA) and The World Health Organization (WHO) have all determined that no level of exposure to asbestos fibers is safe and the material as well as products using asbestos should be permanently banned.

Asbestos was mined for years and was frequently used in the construction industry for an array of products, most often insulation. However, it was determined that exposure to asbestos fibers causes a deadly form of lung cancer known as mesothelioma. Individuals who suffer from mesothelioma cancer should contact an experienced mesothelioma attorney to receive a legal consultation on the possibility of developing a personalized mesothelioma lawsuit. Because the cancer is fatal and no completely effective mesothelioma treatment exists to reduce the disease it may be important to develop litigation and potentially receive monetary compensation to pay for costly medical bills. Mesothelioma is a dormant condition that can take decades before symptoms reveal themselves, at which point, little can be done to improve the illness.

According to news reports, at the Washington D.C. summit, approximately 83 public health officials signed a 29-page report on the "science-for-hire" practice, which Dr. Michael Silverstein, who wrote the report, alleges is occurring on the part of automotive, chemical and mining industries. The report, opposing the request, urged the EPA to focus on public health rather than big industry and to avoid decreasing the asbestos regulations.

Learn more about this ongoing issue as well as other legal issues through LegalView.com. LegalView continues to maintain a comprehensive library of legal issues; issues that may be causing harm to millions of Americans each year. LegalView recently updated several of its issues to include detailed information and news. Some of the recently updated sites include information on the Zimmer Durom cup, the Ketek antibiotic and Avandia prescriptions.

The Durom cup, manufactured by Zimmer Holdings, is an artificial hip component that has been under fire by physicians who have said the device is failing their patients. Because of the alleged Zimmer Durom cup risks, the company has ceased manufacture of the hip socket. However, since production began in 2006, nearly 12,000 patients received the cup and may be affected by the failing hip socket and should contact a knowledgeable attorney for advice about the potential Durom cup recall.

Ketek is a pharmaceutical prescription antibiotic that is used to treat upper respiratory infections including pneumonia or bronchitis. Reports have tied the antibiotic with the possibility of severe liver damage among patients. Additional Ketek side effects may also be considered dangerous and those who report signs of yellowing skin or jaundice should consult a doctor immediately

The Avandia portal is continually being updated to provide the public with extensive research, scientific findings and experienced attorney links. Avandia is a prescription drug used to treat type 2 diabetes, which currently affects millions of individuals in the United States. Recent research, however, has found a disturbing link between the use of Avandia and an increase of heart disease as well as osteoporosis among patients. Individuals who feel they may have symptoms relating to heart disease or who have suffered from a bone fracture likely induced by the Avandia side effects, should speak with a medical expert immediately. Additionally, it is advisable to locate an experienced pharmaceutical law firm in case legal advice is necessary for an Avandia settlement.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

CONTACT INFORMATION
Katie Kelley
LegalView
720-226-6613

Alan Haburchak
LegalView
720-226-6613

Predicted Increase in Female Mesothelioma Victims

2008-08-06T23:34:00.000-05:00

LegalView Informs Mesothelioma Blog Readers of a Predicted Increase in Female Mesothelioma Victims

LegalView updated readers to an alarming prediction by researchers who said the number of female mesothelioma victims may increase within the next few years. Researchers said that asbestos in hair dryers that were previously unregulated may be the cause.

Denver, CO - July 21, 2008 -- LegalView, the most comprehensive legal resource on the Web, reported on its mesothelioma information blog a potential increase of mesothelioma cancer victims within the next few years, particularly among women, according to researchers. In 1979, the U.S. Consumer Product Safety Commission (CPSC) released information regarding 26 companies and manufacturers of hand-held hair dryers that had been made with asbestos. While the 26 companies had voluntarily taken action to correct the asbestos-containing hair dryers, individuals who had used the tainted hair dryers may be at risk for developing mesothelioma and should consider contacting a mesothelioma lawyer for information on the development of a potential mesothelioma lawsuit.

Mesothelioma is a deadly form of lung cancer that is caused through the inhalation of asbestos fibers. While asbestos was largely used in the construction industry, commonly within insulation, it has also been used in other products including hair dryers. While the hair dryers were corrected and became asbestos-free nearly 30 years ago it is common for mesothelioma to remain dormant for years and even decades, which is why researchers are concerned with a new group of individuals becoming afflicted by mesothelioma and symptoms becoming prevalent now. Researchers are also particularly concerned for women because women allegedly use hair dryers more than men. To learn more about developing litigation, contact a mesothelioma law firm or mesothelioma attorney to better understand the potential for developing an asbestos-related lawsuit and receiving monetary compensation for the costly bills usually associated with a mesothelioma cancer diagnosis.

In addition to information on mesothelioma, LegalView also offers details on a plethora of other legal issues afflicting millions of Americans each year. For example, readers can learn about the latest fluoroquinolones black box warning labeling. Fluoroquinolones are a group of antibiotics that have become increasingly at risk for severe side effects. Of the fluoroquinolones group, the most commonly prescribed drugs are Levaquin and Cipro. Levaquin, also known as levofloxacin, is manufactured by Ortho-McNeil and treats bacterial infections, specifically treating infections such as skin infections, chronic bacterial prostates, urinary tract infections, pneumonia, bronchitis and acute pyelonephritis caused by Escherichia coli (E. coli). The drug, which was released in 1996, has been the center of numerous clinical trials and studies because of the possible Levaquin side effects, which can include the most serious - Achilles tendon rupture - as well as jaundice, seizures, hallucinations, abdominal tenderness and limb numbness.

Similar to Levaquin is Cipro (ciprofloxacin) from Bayer A.G., which was approved for market use in 2000 and is used to treat bacterial infections similar to those treated by Levaquin. The Cipro risks are the same as Levaquin, which is an increased risk of tendonitis. Additionally, Cipro has other side effects that may also be harmful to patients. Some of the side effects include seizure, difficulty breathing, depression, suicidal thoughts, blacking out and hallucinations.

LegalView also has information on other controversial prescription drugs including Avandia. Avandia is a type 2 diabetes drug that has recently been linked to severe risks among patients. The Avandia dangers may include an increased risk of heart failure as well as a higher risk of developing early onset osteoporosis. Patients who may have developed either of these side effects while taking Avandia should speak with an experienced pharmaceutical lawyer to better understand the potential for developing a potential Avandia lawsuit.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.

Government Rejects Request to Clean up Asbestos

2008-07-27T17:05:00.000-05:00

LegalView Reports About the Government's Rejection of a Monetary Request to Clean up An Asbestos-Tainted Site

LegalView updated its mesothelioma blog to include news of the government denying federal funds to an area in Arkansas that was left tainted with asbestos after nearly 150 World War II structures were destroyed in a fire. The government rejected the requests from the town of Chaffee Crossing where citizens are currently at risk of contracting mesothelioma cancer.

Denver, CO - LegalView.com, the number one resource for everything legal on the Web, recently reported on its mesothelioma blog that federal funds were denied to cleanup an asbestos-tainted town in Arkansas. Chaffee Crossing is the site of a recent fire, which destroyed nearly 150 World War II (WWII) structures, releasing asbestos fibers and dust into the area potentially increasing the risk of citizens developing mesothelioma. The city requested federal funds from the government to assist the cleanup of the town, which is considered by several citizens there to be a Superfund Site. The Environmental Protection Agency (EPA) is refusing to deem the site a Superfund because it claims that levels of asbestos in the air after the fire were too low to be deemed as such. However, the Arkansas Department of Environmental Quality found asbestos contamination in some areas to be much higher than EPA tests recorded. For those who live in the area or who have previously been exposed to asbestos, using LegalView's mesothelioma portal to locate a mesothelioma attorney is the best way to protect oneself.

Asbestos is a material that is derived from vermiculate, a mineral often mined for uses in construction and as building insulation. Asbestos was widely used as insulation in many early 20th Century constructions, such as those burned in Chaffee Crossing. However, after discovering the link of inhaling asbestos to an incurable form of lung cancer, the use of asbestos was discontinued and the EPA has spent billions of dollars in the removal of asbestos across the country. Individuals who have been exposed to asbestos are advised to contact an experienced mesothelioma law firm to receive an attorney consultation on developing a mesothelioma lawsuit in which compensatory damages can be sought. Mesothelioma is a painful and deadly illness that takes decades to reveal itself, by which time it can be too late to find ways in paying for medical expenses. Use the mesothelioma portal to learn more about this and other recent asbestos-related news.

Additionally, LegalView offers several other information portals relating to a range of issues such as the Baxter Heparin recall, traumatic brain injury (TBI) treatments and Erb's Palsy jury verdicts. Heparin is a blood thinner injected into patients undergoing heart surgery or similar procedures. It is used to prevent blood clots, which can be fatal during surgery. Recently, the Baxter Healthcare Corporation issued a Heparin recall because several patients had reported severe allergic reactions to the drug, which has been associated with at least 19 patient deaths. LegalView.com reported updates continually to readers as this story unfolded, providing insightful and imperative news for victims of the Heparin recall. Similarly, individuals can use the TBI practice area to learn the most up-to-date news on brain injury lawsuits, jury verdicts, treatments as well as how to locate brain injury lawyers.

For information on Erb's Palsy, a condition that usually develops because of labor complications, visit Erb's Palsy lawsuit as the condition is usually preventable and caused by a physician pulling on a baby during birth.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Press Contact: Katie Kelley
Company Name: LegalView
Phone: 720-771-3246
Website: http://mesothelioma.legalview.com

Foundation Funds Follow-up Care in Revolutionary Cancer Vaccine Study

2008-07-27T12:51:00.000-05:00

Onyx and Breezy Foundation Funds Follow-up Care in Revolutionary Cancer Vaccine Study

The Onyx & Breezy Foundation recently funded after-care for dogs engaged in a revolutionary research study to develop a cancer vaccine that may be given to both humans and animals when successful. The study is being conducted at The Matthew J. Ryan Veterinary Hospital, a small animal teaching hospital affiliated with the University of Pennsylvania in Philadelphia.

Tuxedo Park, NY and Philadelphia, PA - March 14 -- The Onyx & Breezy Foundation has announced a gift to The University of Pennsylvania School of Veterinary Medicine. The gift will cover the expense of follow-up care for 12 dogs that are currently enrolled in the School's cancer vaccine study.

"Thanks to this generous gift, more participants in our lymphoma cancer vaccine clinical trial will be able to return for follow-up care," said Dr. Karin Sorenmo, chief of oncology at the Matthew J. Ryan Veterinary Hospital. "This means that we can capture all the data that is needed for the study while pet owners are helped financially."

Prior gifts to The Matthew J. Ryan Veterinary Hospital from the Foundation have been a respirator for their ICU department and a mast cell tumor research study.

Dr. Sorenmo treated Breezy, who had mast cell tumors. "Thanks to Dr. Sorenmo, Breezy lived another 2 years, of quality life, after other vets gave her only 6 weeks to live," said Wanda Shefts. "We are glad that this project will help owners of dogs in remission from lymphoma and help advance Dr. Sorenmo's work on the cancer vaccine.

Dr. Sorenmo stated that she was encouraged by the results and she is hoping that this is just the beginning of more trials that can benefit dogs and ultimately help people. Thanks to this study, a number of the participating dogs are now cancer free. The researchers now estimate that they are within two years of testing the vaccine on humans. Without the dogs, they would be more than a decade away.

"We have a tremendous amount of respect for the work they do at the Hospital and we are glad to be able to fund another project for them", said Mark Shefts.

For more information about Penn Vet, please visit www.vet.upenn.edu; for more information about The Onyx and Breezy Foundation, please visit www.onyxandbreezy.org.

The Onyx and Breezy Foundation Background

The Foundation was created in 2004 and named after the trustees Mark & Wanda Shefts' two Labrador Retrievers. The Foundation lends financial support to organizations that benefit the welfare of animals.

The University Of Pennsylvania School Of Veterinary Medicine Background

Penn's School of Veterinary Medicine is one of the world's premier veterinary schools. Founded in 1884, the School was built on the concept of Many Species, One MedicineTM. The birthplace of veterinary specialties, the School serves a distinctly diverse array of animal patients, from pets to horses to farm animals.

Press Contact: Barbara Kauffman
Company Name: The Onyx & Breezy Foundation
Phone: 201-782-7400
Website: www.onyxandbreezy.org

Baxter Heparin Information on Additional Heparin Recall

2008-07-09T10:32:00.000-05:00

LegalView Expands Baxter Heparin Information Portal to Include Information on an Additional Heparin Recall

LegalView updated its Baxter Heparin information portal to add information on the most recent recall of the blood-thinning drug. Heparin, which is used to control blood during surgical procedures, was recently discovered to have a Heparin-like contaminant that sickened many and caused at least 19 deaths.

Denver, CO - March 31, 2008 -- The Baxter Heparin practice area on LegalView's site, the source for everything legal on the Web, was recently expanded to explain details of an additional Heparin recall . Heparin has been linked to hundreds of allergic reactions among patients as well as having been connected with 19 deaths. B. Braun Medical Inc. issued the most recent recall of Heparin, which was supplied from Scientific Protein Laboratories - the same company that supplied Baxter Healthcare Corporation with the contaminated Baxter Heparin. According to the U.S. Food and Drug Administration (FDA) and B. Braun Medical Inc., no one was reportedly sickened off of the Heparin from B. Braun Medical but it did have a "heparin-like contaminant," which was enough for the company to recall the drug.

Heparin is blood-thinner injected into patients who are undergoing surgical procedures such as heart disease or kidney dialysis. It is a drug that has been imported to the United States since the 1930s and is derived from pig intestines. Many surgeons find that Heparin is an extremely important drug because it prevents blood clots from forming during surgery, which can result in death among patients. However, earlier this year, a rash of individuals who had been given Heparin during a surgical procedure had allergic reactions. Individuals who have been affected by the contaminated Heparin should consider contacting a Heparin lawyer to learn about developing a Heparin class action lawsuit for which compensation may be derived from manufacturers if the tainted drug.

The Baxter Heparin that was initially recalled had been tainted with a chemical known as over-sulfated chondroitin sulfate. Through an FDA investigation, it was discovered that a Chinese company that produces the drug was responsible for the tainted Heparin. Although an investigation continues to be ongoing as to whether the chemical was intentionally or accidentally introduced into a batch of the Heparin. According to news reports, using the over-sulfated chondroitin sulfate allows for a reduction in the production of production for Heparin.

For information on additionally recalled prescription drugs or to report an adverse reaction to a prescribed drug, visit LegalView's many unsafe drugs information portals. Here, readers will find information on recently recalled drugs as well as prescription drugs under investigation such as Chantix, Avandia and Trasylol Aprotinin.

Chantix is a smoking cessation drug from Pfizer that was first introduced to the market, with FDA approval, in mid-2006. However, in late-2007 the FDA began an investigation into nearly 400 reports of suicidal tendencies and behaviors among patients. Additionally, nearly 37 suicides have been associated with the Chantix side effects, which include psychotic episodes, depression, suicidal thoughts and erratic behavior.

Avandia is a prescription drug used to treat diabetes 2 among patients; however, the drug has been linked to several serious side effects including an increased risk of heart disease and a higher chance of early onset osteoporosis. Individuals who are taking Avandia are advised to locate an experienced pharmaceutical law firm to receive consultation on an Avandia lawsuit.

Trasylol, also known as its generic version Aprotinin, is similar to Heparin in that it is used during surgical procedures to control blood loss. A study was released in 2006 from the New England Journal of Medicine, which found that the use of Trasylol Aprotinin increased the chances of a patient developing heart disease, kidney disease, stroke and death. Patients who received or may have received Trasylol or it's generic version should use LegalView's information portal to find an Trasylol attorney.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Press Contact: Katie Kelley
Company Name: LegalView
Phone: 720-771-3246
Website: http://baxter-heparin.legalview.com

Asbestos Contaminated Housing Project Crews Hid Asbestos Leak

2008-07-06T21:13:00.000-05:00

LegalView Releases News on Asbestos Contaminated Housing Project Where Crews Hid Asbestos Leak with Dirt

LegalView reported on its mesothelioma blog about an asbestos contamination that occurred in Miami during the construction of an affordable housing project. The project, now likely to cost five times the original estimate, was contaminated after crews clearing the area hid an asbestos leak with piles of dirt.

Denver, CO - April 12 -- LegalView.com updated its mesothelioma blog with reports of an asbestos contamination that was concealed with piles of dirt by construction crews who were clearing the area for an affordable housing project. The contamination not only increased the risk of exposure to asbestos and thus development of mesothelioma for individuals in the area, but increased the cost of the affordable housing project by five times the originally estimated amount. Individuals living in the area may have been exposed to asbestos fibers and are urged to contact a medical professional as soon as possible. Additionally, Americans who may have been exposed to asbestos should also contact an experienced mesothelioma law firm.

Asbestos is derived vermiculite, a mineral that was heavily mined in the 20th Century. Asbestos was prized for its ability to insulate buildings with a decreased risk of catching fire. It was used for all types of constructions including schools, offices, homes and apartment buildings. However, after discovering that asbestos exposure caused a deadly lung disease among exposed individuals, mining stopped and the Environmental Protection Agency (EPA) was charged with the task of cleaning up any asbestos. Mesothelioma cancer, which is an untreatable form of lung cancer, is often the outcome for individuals who were previously exposed to asbestos. Those who feel they are at risk for this illness should locate an attorney to explore the possibility of a mesothelioma lawsuit.

The area known as North Miami's Pioneer Gardens was expected to house 136 units for low-income individuals. However, when a contractor began digging, it was discovered that workers who had previously cleared the site had inadvertently caused an asbestos leak when underground pipes containing the contaminant were broken. The workers allegedly covered the leak with piles of dirt and it was left until just recently when digging began. It can take years to develop the cancer and even then a mesothelioma diagnosis is often overlooked, causing the cancer to spread among its victim. To learn about the potential for monetary compensation, individuals are advised to contact an experienced mesothelioma lawyer for an attorney consultation on their individual case.

Other issues that are covered on LegalView's Web site, which have largely negatively impacted thousands of Americans recently, include several prescription drugs - Chantix, Singulair, as well as Vytorin and Zetia. Chantix is a smoking cessation drug that is prescribed to millions of Americans struggling to quit their tobacco addiction. In late 2007, the U.S. Food and Drug Administration (FDA) began receiving reports from patients taking Chantix that the drug was linked with instances of depression, erratic behavior and suicidal tendencies and thoughts. Overall, nearly 400 individuals reported this behavior and the drug was also allegedly linked to 37 suicides among patients. The FDA quickly began investigating the drug and are currently studying the Chantix side effects to determine the drug's dangers.

Similar to the dangerous side effects that have been associated with Chantix, are those that have been linked to Singulair, also a prescription drug, which is given to patients who suffer from severe asthma and allergy symptoms. However, in March 2008, reports began to surface about Singulair's potentially dangerous side effects, which may include mood and behavior changes including suicidal behavior among adults and children. The FDA is currently investigating the Singulair risks that may exist with taking this drug.

Vytorin and Zetia are similar in that both are prescription drugs used to lower cholesterol and prevent heart disease among patients. Often Vytorin and Zetia are used in combination of each other and both are manufactured from Merck/Shering-Plough. Recently, the company made headlines because of an extensive study that was completed in 2006 on the two drugs, which detailed the benefits, or lack thereof, of the medications. However, the Zetia and Vytorin manufacturer allegedly delayed the release of the study to the public because findings that Vytorin and Zetia were not as effective as cheaper alternatives. This information has prompted many patients to consider a Vytorin lawsuit.

About LegalView:

LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Press Contact: Katie Kelley
Company Name: LegalView
Phone: 720-771-3246
Website: http://mesothelioma.legalview.com

Sterilisation and Disinfectant Markets in Europe

2008-07-01T12:42:00.001-05:00

Sterilisation and Disinfectant Markets in Europe Enjoy Mixed Fortunes

LONDON-- July 01, 2008 --The sterilisation and disinfectant market in Europe has been witnessing slow growth as hospitals try to tackle alarmingly high infection rates resulting from inadequately decontaminated patient care equipment. However, the market is mature and saturated, offering little scope for technological innovation, and the complete lack of product differentiation is hampering competition. While the disinfection market has shown potential for expansion, the sterilisation market remains largely static.

New analysis from Frost & Sullivan (http://www.medicaldevices.frost.com), European Sterilisation and Disinfection Equipment Market, finds that the market earned revenues of over USD269.7 million in 2007 and estimates this to reach USD352.0 million in 2014.

"Though the sterilisation and disinfection equipment market is not characterised by a strong level of technological development, certain mutations are contributing to the overall positive growth," says Frost & Sullivan Research Analyst Kieu A. Vuong. "For instance, slack growth in the low-temperature gas steriliser segments is compensated by positive trends impacting the disinfector equipment sector."

The spurt in the number of surgical procedures utilising minimally invasive instruments such as endoscopes is also driving the need for sophisticated systems for proper disinfection and maintenance of such equipment. This demand for more efficient disinfecting methods is fuelling the growth of the automatic endoscope reprocessor (AER) segment. The washers and AER disinfection markets are exhibiting continuous growth due to advancements in surgical instrumentation and liquid chemical disinfectants as well.

However, emerging trends indicate increasing consolidation and centralisation of hospitals in Europe, drastically reducing the number of hospitals and the number of potential customers. End-user consolidation is a challenge for this market, as purchasing power is augmented.

"High prices along with slow rate of product replacement will force manufacturers to identify different revenue streams in order to maintain and increase their profit margins," notes Vuong. "Despite several attempts at creating a unified platform, insecurities concerning the standardisation and regulation of products continue."

Nonetheless, participants can accrue revenues by providing integrated service packages and proper nurturing of customer relationships, since virtually all hospitals are already equipped with infection control equipment. To achieve the high standards required for service packages, many companies have entered into partnerships to reduce costs and enhance their offering.

If you are interested in a virtual brochure, which provides manufacturers, end users and other industry participants with an overview of the European sterilisation and disinfection equipment market, then send an e-mail to Patrick Cairns, Corporate Communications, at pcairns_pr@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.

European Sterilisation and Disinfection Equipment Market is part of the Medical Devices Growth Partnership Service programme, which also includes research in the following markets: cardiovascular, wound care, surgical, orthopaedic and others. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, the Growth Partnership Company, partners with clients to accelerate their growth. The company's TEAM Research, Growth Consulting and Growth Team MembershipT empower clients to create a growth-focused culture that generates, evaluates and implements effective growth strategies. Frost & Sullivan employs over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 30 offices on six continents. For more information about Frost & Sullivan's Growth Partnerships, visit http://www.frost.com.

European Sterilisation and Disinfection Equipment Market

M236

Contacts

Frost & Sullivan
Corporate Communications - Europe & Africa
Patrick Cairns, +27 18 468 2315
patrick.cairns@frost.com
or
Corporate Communications - North America
Stacie Kopecki, 210-247-2450
fax: 210-348-1003
stacie.kopecki@frost.com
or
Corporate Communications - Asia Pacific
Jasminder Kaur, 65-6890-0937
fax: 65-6890-0988
jkaur@frost.com
or
Corporate Communications - South Asia
Remi Chatterjee, +91-44-4001 3419
fax: +91-22-2832 4713
remi.chaterjee@frost.com
or
Corporate Communications - Middle East
Nimisha Iyer, +91 22 4001 3404
fax: +91 22 2832 4713
niyer@frost.com
or
Corporate Communications - China
Amelia Wong, +86 21 5407 5783, ext. 8669
cell: +86 13621724823
amelia.wong@frost.com
or
Corporate Communications - Latin America
José María Jantus, + 54-11-4777-9951
fax: + 54-11-4777-0071
jose.jantus@frost.com
http://www.frost.com

New Patient Safety Solution Supported By Pharmacy Technician Certification Board

2008-06-28T21:14:00.000-05:00

Pharmacy Technician Certification Board (PTCB) Supports Florida's New Patient Safety Solution

The Pharmacy Technician Certification Board (PTCB), the leading national program that has certified more than 300,000 pharmacy technicians, supports and congratulates the Florida House of Representatives and Governor Charlie Crist for passing legislation requiring new standards for pharmacy technicians. The new Florida legislation takes a progressive step toward increasing patient safety for consumers. The legislation will ensure pharmacy technicians meet key requirements for training, certification and registration.

Washington, D.C. - June 27, 2008 -- The Pharmacy Technician Certification Board (PTCB) (http://www.ptcb.org/), the leading national program that has certified more than 300,000 pharmacy technicians, is pleased to support and congratulate the Florida Legislature for passing SB 1360 and Governor Charlie Crist for signing it into law, requiring new standards for pharmacy technicians. Tireless advocacy efforts for the passage of this critical patient safety legislation and its final approval by Governor Crist were spearheaded by the Florida Society of Health-System Pharmacists (FSHP) and the Florida Pharmacy Association (FPA).

The new Florida legislation takes a progressive step toward increasing patient safety for consumers. By passing this legislation without amendment, and signing it into law, the Florida state legislature and governor will ensure pharmacy technicians meet key requirements for training, certification and registration. PTCB is proud to have certified 15,000 pharmacy technicians in Florida to date and looks forward to working with more pharmacy technicians and their employers.

"Florida's new pharmacy technician standards are an important patient safety solution for consumers in the Sunshine State and Governor Crist and the state's legislators should be applauded," said PTCB Executive Director and CEO Melissa Murer Corrigan. "To meet these new state standards, PTCB is looking forward to continued work with pharmacy technicians and significant employers of Florida's pharmacy technicians such as Walgreen's, CVS, Publix, Target, the U.S. military, multiple health-systems and independent pharmacists in communities across the state. Several of these employers presently support and endorse PTCB across the United States."

The landmark piece of Florida legislation (SB 1360) contributes to raising the bar for states across the country by providing an example of the high standards needed for pharmacy technicians. The more than 40,000 pharmacy technicians currently working in Florida will be required to register with the Florida Board of Pharmacy by 2010. In 2011, they will need to either complete a board-approved training program with 1,500 hours of work as a technician under a Florida licensed pharmacist, or be certified (https://www.ptcb.org/AM/Template.cfm?Section=Guidebook_to_Certification&Template=/CM/HTMLDisplay.cfm&ContentID=2952) by a program accredited by the National Commission for Certifying Agencies (NCCA). PTCB is the pioneer in certifying pharmacy technicians (https://www.ptcb.org/AM/Template.cfm?Section=Learn&Template=/CM/ContentDisplay.cfm&ContentID=1384) and is accredited by the NCCA. PTCB's certification program has been included in regulations by more than 30 state boards of pharmacy. Through its strategic partnership with Pearson VUE, PTCB is able to offer highly scalable computer-based testing through the world's largest network of testing centers.

Studies show without a doubt that Americans support a standard of excellence for pharmacy technicians. A recent poll commissioned by PTCB confirms that 91% of American consumers support strong regulations across the country to protect patient safety by requiring that pharmacy technicians are trained and certified. While states like Florida reflect this growing need for action, almost twenty other states still have no requirement for certification. Clearly, consumers are relying on state boards of pharmacy to protect them and enact strong requirements such as Florida's for pharmacy technicians.

About the Pharmacy Technician Certification Board (PTCB) (http://www.ptcb.org/)

PTCB was established in January 1995 and is governed by five pharmacy organizations - the American Pharmacists Association (APhA), the American Society of Health-System Pharmacists (ASHP), the Illinois Council of Health-System Pharmacists (ICHP), the Michigan Pharmacists Association (MPA) and the National Association of Boards of Pharmacy (NABP). Since PTCB's inception, PTCB has certified over 300,000 pharmacy technicians through the examination and transfer process. PTCB's certification program is accredited by the National Commission for Certifying Agencies (NCCA). The goal of the PTCB national certification program is to enable pharmacy technicians to work more effectively with pharmacists to offer safe and effective patient care and service. PTCB contracts with Pearson VUE, the industry's technology leader, as its computer-based testing vendor. PTCB draws upon the experience and expertise of its 13-year partner, Professional Examination Service (PES) for test development.

Contact Information
Mark Franco
The Pharmacy Technician Certification Board
http://www.ptcb.org
202-429-7508
202-828-9767

Suboxone Treatment Program Launched

2008-06-27T20:51:00.000-05:00

InterventionTreatment.com Launches Suboxone Treatment Program

LOS ANGELES-- June 27, 2008 --Intervention Treatment announced today that it has launched a suboxone treatment program. The program will be used to increase Intervention Treatment's Global mission of providing Intervention and Treatment resources to those affected by alcohol and drug addiction. According to Dr. Jason Schiffman, Chief Medical Officer for Intervention Treatment, "There is a large, poorly met demand for outpatient, office-based treatment of opiate dependence and the addition of the suboxone treatment program to Intervention Treatment's array of alcohol and drug addiction related services will be a great tool for patients and their families."

Intervention Treatment is currently one of the fastest growing online resources for those affected by drug and alcohol addiction. The new Suboxone Treatment program is designed to help those affected by opiate addiction.

About Suboxone:

Suboxone is the first drug approved by the FDA for opiate dependence treatment in office based settings. This means that patients addicted to opiates may now choose to receive opiate-based treatment as an outpatient instead of in a hospital setting. Patients are evaluated and treated during office visits and receive a prescription for suboxone which they may fill at any pharmacy. Suboxone is comprised of two separate medications: buprenorphine and naloxone. Buprenorphine is a partial opiate agonist, meaning its opiate effects are significantly reduced compared to that of full opiate agonists, such as vicodin or heroin. The naloxone in suboxone is not appreciably absorbed from the digestive track when suboxone is taken orally and is in place to prevent the misuse of suboxone by injection drug users. The combination of these two medications leads to suboxone's effectiveness in treating opiate dependence.

About Suboxone Treatment:

Suboxone treatment differs significantly from standard opiate dependence treatment programs. Traditionally, opiate addicts undergoing medical detoxification have been administered either methadone or a combination of drugs, each targeting a symptom of withdrawal. The latter approach usually must take place in an inpatient setting in order to be done safely, while methadone treatment requires a patient to visit a clinic on a daily basis to receive a prescribed dose. Suboxone treatment differs from these treatments in several important ways. Firstly, a prescription for suboxone can be obtained at a specially licensed physician's office and filled at any pharmacy. This means the patient does not need to be admitted to a hospital or make daily visits to a methadone clinic in order to receive their medication. Secondly, because suboxone is a mixture of naloxone and buprenorphine, a partial opiate agonist with a long duration of action, the potential for abuse and overdose are much less than with methadone. Thirdly, because buprenorphine is a partial opiate agonist, suboxone may be easier to taper off of than full opiate agonists like methadone.

About Intervention Treatment

Intervention Treatment, formed in 2007, is an internet resource offering help to those affected by drug and alcohol addiction. Intervention Treatment provides referrals to drug and alcohol rehabs, intervention services, suboxone treatment referrals, and general information regarding addiction and treatment.

Safe Harbor Statement

This press release contains statements that may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of the Company, and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.
Contacts

Intervention Treatment
William Donovan, Co-Founder, 949-267-4113
bj@interventiontreatment.com
www.interventiontreatment.com

Physician Practice Documentation Receives CCHIT Certification

2008-06-18T15:05:00.000-05:00

Dairyland Healthcare Solutions' Physician Practice Documentation Receives 2007 CCHIT Certification

Software Complies with 100 Percent of Updated 2007 Certification Criteria

GLENWOOD, Minn.-- June 18, 2008 --The Certification Commission for Healthcare Information Technology (CCHIT®) today announced that Dairyland Healthcare Solutions' Physician Practice Documentation (PPD), Version 9.0.0 is CCHIT Certified®, and meets the Commission's ambulatory electronic health record (EHR) criteria for 2007. Ambulatory EHRs are designed for physician offices and clinics where most Americans get their healthcare. CCHIT - an independent, nonprofit organization - is the Recognized Certification Body in the United States for certifying health information technology products.

In the second year of the program's operation, the criteria and testing have been significantly enhanced. The Commission added 96 criteria to the 151 original requirements from last year. As a CCHIT Certified product has been tested and passed inspection of 100 percent of a set of updated criteria for functionality, interoperability and security.

"For 2007, the Commission raised the bar from the previous year's criteria. Ambulatory EHRs now must include electronic prescribing, demonstrate an ability to receive lab results, and show enhanced patient safety, quality, and security features," said Mark Leavitt, M.D., Ph.D., chair, CCHIT. "Investment in 2007 certified ambulatory EHRs gives providers even more powerful tools to improve quality, safety and efficiency while protecting the privacy of health information."

The CCHIT Certified mark - a "seal of approval" for EHR products - provides the first consensus-based, government-recognized benchmark for ambulatory EHR products. By looking to products with the CCHIT Certified seal, physicians and other providers can reduce their risk in selecting an EHR product, allowing them to focus their evaluation on the special needs of their practices.

"We are delighted to receive CCHIT certification," said James Burgess, CEO of Dairyland. "The CCHIT review process is rigorous and essential to ensuring that technologies carrying this important certification meet the highest safety and quality standards. We are pleased that CCHIT recognizes Dairyland's high standards," he added.

CCHIT's certification compliance criteria and its design for a certification inspection process have been thoroughly researched, taking into account the state of the art of EHRs and available standards, and comparing certification processes in other industries and other countries. The inspection process is based on real-life medical scenarios designed to test products rigorously against the clinical needs of providers and the quality and safety needs of healthcare consumers and payers. One script, for example, recreates a scenario of an elderly man with poorly controlled diabetes, hypertension and other chronic conditions in order to test EHR functions such as potential adverse drug reactions, disease management and treatment plans.

About Dairyland Healthcare Solutions

Dairyland Healthcare Solutions is an award-winning healthcare information systems company that links essential information between small community hospitals and their healthcare delivery and business networks. Dairyland enables its hospital partners to deliver the highest level of patient care by providing the information infrastructure required to operate effectively in the dynamic and complex healthcare delivery environment. For almost three decades, Dairyland has partnered with leading community hospitals to help them improve efficiencies, enhance profitability and ensure patient safety by providing solutions to manage, integrate and access key financial, clinical and patient information. Dairyland is the only company to be awarded three consecutive "Best in KLAS" ratings in the Community Hospital Information Systems category. To learn more, visit: http://www.dhsnet.com.

About CCHIT

The Certification Commission for Healthcare Information Technology (CCHIT®) is an independent, nonprofit organization that has been named by the federal government as the Recognized Certification Body for health information technology. Its mission is to accelerate the adoption of health information technology by creating a credible, sustainable certification program. The certification requirements are based on widely accepted industry standards and involve the work of hundreds of expert volunteers and input from a variety of stakeholders throughout the health care industry. More information on CCHIT and CCHIT Certified® products is available at www.cchit.org.

"CCHIT®" and "CCHIT Certified®" are service marks of the Certification Commission for Healthcare Information Technology.

Contacts

Dairyland Healthcare Solutions
Tracey Schroeder, 612-787-3125
VP Marketing & Communications
tracey.schroeder@dhsnet.com
or
CCHIT
Sue Reber, 503-703-0813
sreber@cchit.org

Victims of Asbestos Exposure Should Call the Mesothelioma Victims Center

2008-06-08T20:49:00.001-05:00

Mesothelioma Victims And All Victims of Asbestos Exposure Should Call the Mesothelioma Victims Center First For Free Honest Advise & Help

Why should victims of mesothelioma or their families call the Mesothelioma Victims Center First? According to Americas Watchdog, "its pretty simple, we will tell them the truth about treatment options, lawyers, Social Security, and everything else they need to know and our service is free". The Mesothelioma Victims Center was created to assist all US victims of Mesothelioma. Americas Watchdog has initiated this very complete free service because there is literally nothing close to this type of service in the United States, and because this type of service is sorely needed by Mesothelioma victims and their families. The Mesothelioma Victims Center was created to assist victims & their families in every way possible. Victims who served in the US Navy are especially encouraged to contact the group at 866-714-6466.

May 27, 2008 -- The Mesothelioma Victims Center is a free service designed to assist all victims of Mesothelioma, or to assist the families of victims who have this disease. What makes this service unique? According to Americas Watchdog,"our service to victims or their families is free. Mesothelioma is a rare, and lethal form of cancer related to asbestos exposure. Americas Watchdog never realized that there was no safety net for victims, to get help from the government or VA. They did not know how difficult it might be to get veterans benefits or social security benefits. Americas Watchdog also discovered that it is critical for victims of this lethal disease to get proper legal representation. They have designed the Mesothelioma Victims Center to be the national advocacy center for the victims and family members of Mesothelioma.Their service is free. The web site is located at http://MesotheliomaVictimsCenter.com.

Very Important note: According to the Mesothelioma Victims Center, "You do not want a personal injury attorney with little, to no Mesothelioma experience taking on a case, unless they have lots of experience with mesothelioma. This is especially true of US Navy veterans, who were exposed in a US naval vessel engine room. If you, or a loved one has been diagnosed with Mesothelioma, there are thousands of law firms that say they can take the case. The problem; there are only a handful of law firms in the US that can do a superior job."

According to Americas Watchdog, "Individuals who have been diagnosed with Mesothelioma, or their family members should call the Mesothelioma Victims Center first, for honest and straight forward advice at 866-714-6466". The Mesothelioma Center is all about honest, and helpful advice for all Mesothelioma victims. The Mesothelioma Victims Center web site is located at Http://MesotheliomaVictimsCenter.com.

The Mesothelioma Victims Center's services include:

* Assisting the victims of Mesothelioma in obtaining Social Security permanent disability payments

* If the victim is a veteran and was exposed to asbestos during military duty, we will work with the victim and his/her family in obtaining veterans disability and health care benefits.

* We will assist the family in getting the best possible health care options

* We will assist the victim in getting legal representation.

* We will assist the victim and their family in getting counseling on a wide variety of topics that arise from this disease.

A victim of Mesothelioma or their family can call the group any time for help, assistance and advice anytime at 866-714-6466.

Who Can Get Mesothelioma? Individuals exposed to asbestos. As Follows

* Individuals who served in the US Navy. Especially Navy personnel who served in or around naval ship engine rooms.

* Members of the US Army, Air Force, Marines, or Coast Guard.

* Naval ship yard workers

* Oil refinery workers

* Ship yard workers

* Automotive repair specialists

* Construction workers

* Plumbers

* Demolition contractors

Important note to doctors and medical staff: Please tell your patients about the Mesothelioma Victims Center.

Because no other group is providing this full range of services, and because victims and their families need assistance in these areas, Americas Watchdog is doing all of this at no charge, because its the right thing to do. Americas Watchdog's Mesothelioma Victims Center web site is located at http://MesotheliomaVictimsCenter.com. Anyone wishing more information can call the Mesothelioma Victims Center anytime at 866-714-6466. Health care workers or physicians are encouraged to tell your patients about the Mesothelioma Victims Center.

Americas Watchdog and its Mesothelioma Victims Center are all about taking care of precious souls in need, and corporate responsibility.

Contact Information
THOMAS MARTIN
Americas Watchdog
Http://MesotheliomaVictimsCenter.Com
866-714-6466

Should Mesothelioma Victims Call A Mesothelioma Victims Center?

2008-05-26T14:46:00.000-05:00

Mesothelioma Victims Should Call Americas Watchdog's Mesothelioma Victims Center

If you are a victim of Mesothelioma or a family member friend of a victim Americas Watchdog is there for you. Americas Watchdog has created the Mesothelioma Victims Center as a free service to victims or family members of victims, of a rare form of cancer called Mesothelioma. Americas Watchdog has initiated this very complete free service because there was literally nothing close to this type of service in the United States and because this type of service is sorely needed by Mesothelioma victims and their families. The Mesothelioma Victims Center was created to assist victims & their families in every way possible

April 21, 2008 -- Americas Watchdog has created the most wonderful service for victims or family members of victims of Mesothelioma. Until a family member was diagnosed with Mesothelioma, Americas Watchdog had never heard of this disease or knew much about it. Mesothelioma is a rare and lethal form of cancer. Mesothelioma is caused by exposure to asbestos. The group never realized that there was no safety net for victims, to get help from the government. They did not know how difficult it might be to get veterans benefits or social security benefits. Americas Watchdog also discovered that it is critical for victims of this lethal disease to get proper legal representation. They have designed the Mesothelioma Victims Center to be the national advocacy center for the victims and family members of Mesothelioma.Their service is free. The web site is located at http://MesotheliomaVictimsCenter.com.

Their services include:
* Assisting the victims obtain Social Security permanent disability payments
* If the victim is a veteran and was exposed to asbestos during military duty, we will work with the victim and his/her family in obtaining veterans disability and health care benefits.
* We will assist the family in getting the best possible health care options
* We will assist the victim in getting legal representation.
* We will assist the victim and their family in getting counseling on a wide variety of topics that arise from this disease.
A victim of Mesothelioma or their family can call the group any time at 866-714-6466.

Who Can Get Mesothelioma? Individuals exposed to asbestos. As Follows
* Individuals who served in the US Navy. Especially Navy personnel who served in or around naval ship engine rooms.
* Members of the US Army, Air Force, Marines, or Coast Guard.
* Naval ship yard workers
* Ship yard workers
* Automotive repair specialists
* Construction workers
* Plumbers
* Demolition contractors

Because no other group is providing this full range of services and because victims and their families need assistance in these areas, Americas Watchdog is doing this at no charge because its the right thing to do. Americas Watchdog's Mesothelioma Victims Center web site is located at Http://MesotheliomaVictimsCenter.Com . Any one wishing more information can call the Mesothelioma Victims Center anytime at 866-714-6466.

Americas Watchdog and its Mesothelioma Victims Center are all about taking care of precious souls in need and corporate responsibility.

Press Contact: THOMAS MARTIN
Company Name: Americas Watchdog
Phone: 866-714-6466
Website: Http://MesotheliomaVictimsCenter.Com

Mesothelioma Blog Reports on Man Fired for Reporting Asbestos Cleanup

2008-05-21T15:05:00.000-05:00

LegalView Mesothelioma Blog Reports on Whistleblower Who Was Allegedly Fired for Reporting Improper Asbestos Cleanup to Authorities

LegalView recently updated its mesothelioma blog to include reports of a whistleblower being fired after he reported improper asbestos cleanup. The worker who refused to sign off on the demolition of the school was dismissed from his job duties permanently after he reported the improper procedure cleanup to officials.

Denver, CO - April 18, 2008 -- LegalView, the number one resource for everything legal on the Web, recently updated its mesothelioma blog with news of the firing of an alleged whistleblower who attempted to report improper asbestos cleanup of a local high school. The city worker was part of a crew that was to demolition an old schoolhouse. The worker allegedly told city managers that the schoolhouse was filled with asbestos and would be hazardous if improper asbestos removal procedures were not followed. However, after the worker refused to sign off on the demolition and spoke out, he was fired, according to reports.

Asbestos is a hazardous chemical that is often found in insulation of many older buildings including government buildings, offices, homes, apartments, universities and schools. It is derived of vermiculite, which was heavily mined early on in the 20th century throughout the world. Asbestos was revered for its qualities of being cost efficient and its ability to insulate sufficiently without catching on fire as easily as other insulations. However, it was discovered that breathing in asbestos fibers and dust caused a deadly form of lung cancer to develop. Additionally, areas that currently contain asbestos must follow strict procedures and methods from the Environmental Protection Agency (EPA) for removal, otherwise asbestos fibers will likely be released into the air and contaminate surrounding areas and individuals. Those who feel they have been previously exposed to asbestos fibers should contact a mesothelioma lawyer for immediate assistance on building a case.

Mesothelioma cancer can take years to develop and is incurable. It is often misdiagnosed, as symptoms of mesothelioma cancer are similar to many other illnesses. Individuals who have contracted mesothelioma should speak with an experienced medical attorney and receive a consultation on a potential mesothelioma lawsuit. To learn more about this recent mesothelioma blog posting as well as additional up-to-date news, reports and information on recent mesothelioma jury verdicts, visit http://mesothelioma.legalview.com/.

In addition to the extensive mesothelioma information portal, LegalView offers information on an assortment of other legal issues that may disrupt the lives of millions of Americans. Information on issues such as pharmaceutical investigations, including the latest Singulair recall, preventable conditions like Erb's Palsy, diseases, illnesses, accidents, chemical exposure, employment discrimination, etc.

LegalView even provides news on the most recent traumatic brain injury treatments, available through LegalView's Web site. Also on the brain injury site, readers can find information on what may be involved with filing a brain injury lawsuit.

On the Singulair practice area, readers will be able to access the latest news on the prescription drug, which had been under investigation by the U.S. Food and Drug Administration (FDA) after reports began to surface about Singulair side effects that can allegedly include moodiness, suicidal behaviors and thoughts.

Additionally, using the Erb's Palsy information portal will provide victims and their families insight into the cause of their condition as well as opportunities for developing an Erb's Palsy lawsuit for potential monetary compensation to help pay for costly medical bills commonly associated with this condition. Erb's Palsy can be a debilitating condition and is usually preventable. It is associated with birth-canal complications that have occurred when an infant's shoulders or head became lodged, causing damage to the nerve system controlling arm movement. While Erb's Palsy often can clear on its own through time, many individuals still require physical therapy and many will need surgery to fix their condition. Those who suffer from this disease are advised to use LegalView's site to easily be referred to a qualified Erb's Palsy lawyer.

About LegalView:
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com.

Press Contact: Katie Kelley
Company Name: LegalView
Phone: 720-771-3246
Website: http://mesothelioma.legalview.com

Center to Assist All Victims of Mesothelioma

2008-05-18T22:03:00.001-05:00

Mesothelioma Victims Center to Assist All Victims of Mesothelioma

Americas Watchdog has created the Mesothelioma Victims Center as a free service to victims or family members of victims, of a rare form of cancer called Mesothelioma. Americas Watchdog has initiated this very complete free service because there was literally nothing close to this type of service in the United States and because this type of service is sorely needed by Mesothelioma victims and their families. The Mesothelioma Victims Center was created to assist victims & their families in every way possible.

April 16, 2008 -- Americas Watchdog has just opened its Mesothelioma Victims Center, as a way to assist and protect victims of a rare form of cancer called Mesothelioma. The service is free to Mesothelioma victims or their families.

Until a family member was diagnosed with Mesothelioma, Americas Watchdog had never heard of this disease or knew much about it. Mesothelioma is a rare and lethal form of cancer. Mesothelioma is caused by exposure to asbestos. The group never realized that there was no safety net for victims, to get help from the government. They did not know how difficult it might be to get veterans benefits or social security benefits. Americas Watchdog also discovered that it is critical for victims of this lethal disease to get proper legal representation. They have designed the Mesothelioma Victims Center to be the national advocacy center for the victims and family members of Mesothelioma.Their service is free.

Their services include:
* Assisting the victims obtain Social Security permanent disability payments
* If the victim is a veteran and was exposed to asbestos during military duty, we will work with the victim and his/her family in obtaining veterans disability and health care benefits.
* We will assist the family in getting the best possible health care options
* We will assist the victim in getting legal representation.
* We will assist the victim and their family in getting counseling on a wide variety of topics that arise from this disease. A victim of Mesothelioma or their family can call the group any time at 866-714-6466.

Who Can Get Mesothelioma?

* Individuals who served in the US Navy. Especially Navy personnel who served in or around naval ship engine rooms.
* Members of the US Army, Air Force, Marines, or Coast Guard.
* Naval shop yard workers
* Ship yard workers
* Automotive repair specialists
* Construction workers
* Plumbers
* Demolition contractors

Because no other group is providing this full range of services and because victims and their families need assistance in these areas, Americas Watchdog is doing this at no charge because its the right thing to do. Americas Watchdog's Mesothelioma Victims Center web site is located at Http://MesotheliomaVictimsCenter.Com . Any one wishing more information can call the Mesothelioma Victims Center anytime at 866-714-6466.

Americas Watchdog and its Mesothelioma Victims Center are all about taking care of precious souls in need and corporate responsibility.

Press Contact: THOMAS MARTIN
Company Name: Americas Watchdog
Phone: 866-714-6466
Website: http://MesotheliomaVictimsCenter.Com

Oral Cancer Now Covered under Specialty Benefits Dental Plans

2008-05-13T12:08:00.001-05:00

`Early Warning' for Oral Cancer Now Covered under UnitedHealthcare Specialty Benefits Dental Plans

Coverage Applies to New Screening Test Used by Dentists

GOLDEN VALLEY, Minn.-- May 13, 2008 --UnitedHealthcare Specialty Benefits now provides coverage under all of its insured dental plans for a new oral cancer screening test for potential abnormalities inside the mouth, including premalignant lesions and oral cancer.

The test, which uses light-contrast technology, can improve a dentist's ability to identify, evaluate and monitor lesions that are difficult to see using visual inspection under conventional lighting.

"Evidence shows that dentists can serve as a valuable 'early warning' system for patients who have signs of oral cancer," said Dr. Michael Weitzner, vice president of clinical product development for UnitedHealthcare Specialty Benefits dental unit.

More than 34,000 Americans will be diagnosed with oral or pharyngeal cancer this year. The death rate associated with this cancer is particularly high - not because it is hard to discover or diagnose, but due to the cancer being routinely discovered late in its development. Studies confirm that survival does correlate with stage, making early diagnosis and treatment optimal for this disease and may have a positive impact on an individual's medical costs (Journal of the American Dental Association, Vol. 132, Nov. 2001).

By covering this type of oral cancer screening, UnitedHealthcare Specialty Benefits dental unit is renewing its longstanding commitment to early detection of oral cancer. In addition to oral cancer screening, UnitedHealthcare Specialty Benefits dental plans have covered brush biopsies since 2005 when the American Dental Association first introduced a current dental terminology (CDT) code for the procedure. Screening is covered once a year for individuals, starting at age 30. UnitedHealthcare Specialty Benefits' focus on wellness continues to build programs and plan enhancements that promote individuals' ability to better manage their overall health as well as their future medical and dental costs.

About UnitedHealthcare Specialty Benefits

UnitedHealthcare Specialty Benefits offers a broad array of specialty benefits, including vision, dental, group and voluntary insurance, worksite individual insurance and non-insurance programs. UnitedHealthcare Specialty Benefits is a business unit of OptumHealth, the health and wellness unit of UnitedHealth Group, Inc. (NYSE:UNH). More information about OptumHealth can be found at www.optumhealth.com/.

Contacts

OptumHealth
Ann Fleischauer, Director, External Communications
763-797-2652